Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 2346Neoplasms 1710Prostatic Neoplasms 1192Lung Neoplasms 924Colorectal Neoplasms 877Carcinoma, Non-Small-Cell Lung 864Leukemia, Myeloid, Acute 592Pancreatic Neoplasms 578Multiple Myeloma 547Carcinoma, Hepatocellular 513Brain Neoplasms 511Neoplasm Metastasis 460Head and Neck Neoplasms 453Melanoma 415Ovarian Neoplasms 410Precursor Cell Lymphoblastic Leukemia-Lymphoma 400Glioblastoma 397Stomach Neoplasms 377Uterine Cervical Neoplasms 362Squamous Cell Carcinoma of Head and Neck 361Rectal Neoplasms 340Recurrence 334Sarcoma 324Hematologic Neoplasms 323Colonic Neoplasms 323Lymphoma 320Triple Negative Breast Neoplasms 292Carcinoma, Renal Cell 283Urinary Bladder Neoplasms 281Glioma 276

Interventions

thymoglobulin 1prednylidene 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Etoposide 1Cytarabine 1Carmustine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Opsoclonus-Myoclonus Syndrome × 1 year × Clear all
NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
53 enrolled
CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡